Multiple Myeloma Molecular Monitoring Study
Study Description
“Multiple Myeloma Molecular Monitoring Study”
The investigators will track 250 multiple myeloma patients across Canada over time, using new lab tests to evaluate their blood and bone marrow, as they receive standard of care treatment. The main hypothesis is that these tests will allow clinicians to better diagnose and manage multiple myeloma, improving patients' quality of life overall.
Location
Methods
No pharmaceutical medication involved
Recruiting patients only
Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.
Additional Information
Official Study Title
The Terry Fox Pan-Canadian Multiple Myeloma Molecular Monitoring Study
Clinical Trial ID
NCT03421132
ParticipAid ID
Xe0JVb
